OBJECTIVES: Prevalence of microalbuminuria is increased in patients with HIV. Microalbuminuria is associated with increased mortality in other populations, including diabetics, for whom microalbuminuria testing is standard of care. We investigated whether microalbuminuria is associated with mortality in HIV-infected women not receiving antiretroviral therapy. METHODS: Urinalysis for proteinuria and semiquantitative testing for microalbuminuria were performed in specimens from 2 consecutive visits in 1547 HIV-infected women enrolled in the Women's Interagency HIV Study in 1994-1995. Time to death was modeled using proportional hazards analysis. RESULTS: Compared with women without albuminuria, the hazard ratio (HR) for all-cause mortality was increased in women with 1 (HR: 3.4; 95% CI: 2.2 to 5.2) or 2 specimens positive for either proteinuria or microalbuminuria (HR: 3.9; 95% CI: 2.1 to 7.0). The highest risk was observed in women with both specimens positive for proteinuria (HR: 5.8; 95% CI: 3.4 to 9.8). The association between albuminuria and all-cause mortality risk remained significant after adjustment for demographics, HIV disease severity, and related comorbidities. Similar results were obtained for AIDS death. CONCLUSIONS: We identified a graded relationship between albuminuria and the risk of all-cause and AIDS mortality.
OBJECTIVES: Prevalence of microalbuminuria is increased in patients with HIV. Microalbuminuria is associated with increased mortality in other populations, including diabetics, for whom microalbuminuria testing is standard of care. We investigated whether microalbuminuria is associated with mortality in HIV-infectedwomen not receiving antiretroviral therapy. METHODS: Urinalysis for proteinuria and semiquantitative testing for microalbuminuria were performed in specimens from 2 consecutive visits in 1547 HIV-infectedwomen enrolled in the Women's Interagency HIV Study in 1994-1995. Time to death was modeled using proportional hazards analysis. RESULTS: Compared with women without albuminuria, the hazard ratio (HR) for all-cause mortality was increased in women with 1 (HR: 3.4; 95% CI: 2.2 to 5.2) or 2 specimens positive for either proteinuria or microalbuminuria (HR: 3.9; 95% CI: 2.1 to 7.0). The highest risk was observed in women with both specimens positive for proteinuria (HR: 5.8; 95% CI: 3.4 to 9.8). The association between albuminuria and all-cause mortality risk remained significant after adjustment for demographics, HIV disease severity, and related comorbidities. Similar results were obtained for AIDS death. CONCLUSIONS: We identified a graded relationship between albuminuria and the risk of all-cause and AIDS mortality.
Authors: Daniel E Weiner; Hocine Tighiouart; Manish G Amin; Paul C Stark; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak Journal: J Am Soc Nephrol Date: 2004-05 Impact factor: 10.121
Authors: K Anastos; L A Kalish; N Hessol; B Weiser; S Melnick; D Burns; R Delapenha; J DeHovitz; M Cohen; W Meyer; J Bremer; A Kovacs Journal: AIDS Date: 1999-09-10 Impact factor: 4.177
Authors: H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf Journal: JAMA Date: 2001-07-25 Impact factor: 56.272
Authors: S E Barkan; S L Melnick; S Preston-Martin; K Weber; L A Kalish; P Miotti; M Young; R Greenblatt; H Sacks; J Feldman Journal: Epidemiology Date: 1998-03 Impact factor: 4.822
Authors: Lynda Anne Szczech; Donald R Hoover; Joseph G Feldman; Mardge H Cohen; Stephen J Gange; Lisa Goozé; Nancy R Rubin; Mary A Young; Xiaotao Cai; Qiuhu Shi; Wei Gao; Kathryn Anastos Journal: Clin Infect Dis Date: 2004-09-27 Impact factor: 9.079
Authors: Lytt I Gardner; Scott D Holmberg; John M Williamson; Lynda A Szczech; Charles C J Carpenter; Anne M Rompalo; Paula Schuman; Robert S Klein Journal: J Acquir Immune Defic Syndr Date: 2003-02-01 Impact factor: 3.731
Authors: Lynda Anne Szczech; Carl Grunfeld; Rebecca Scherzer; Jesse A Canchola; Charles van der Horst; Stephen Sidney; David Wohl; Michael G Shlipak Journal: AIDS Date: 2007-05-11 Impact factor: 4.177
Authors: Mardge H Cohen; Audrey L French; Lorie Benning; Andrea Kovacs; Kathryn Anastos; Mary Young; Howard Minkoff; Nancy A Hessol Journal: Am J Med Date: 2002-08-01 Impact factor: 4.965
Authors: Takashi Shinha; Deming Mi; Ziyue Liu; Christie M Orschell; Michael M Lederman; Samir K Gupta Journal: AIDS Res Hum Retroviruses Date: 2015-02-26 Impact factor: 2.205
Authors: Christina M Wyatt; Douglas Kitch; Samir K Gupta; Camlin Tierney; Eric S Daar; Paul E Sax; Belinda Ha; Kathleen Melbourne; Grace A McComsey Journal: J Acquir Immune Defic Syndr Date: 2014-09-01 Impact factor: 3.731
Authors: Leonard Msango; Jennifer A Downs; Samuel E Kalluvya; Benson R Kidenya; Rodrick Kabangila; Warren D Johnson; Daniel W Fitzgerald; Robert N Peck Journal: AIDS Date: 2011-07-17 Impact factor: 4.177
Authors: Michael G Shlipak; Rebecca Scherzer; Alison Abraham; Phyllis C Tien; Carl Grunfeld; Carmen A Peralta; Prasad Devarajan; Michael Bennett; Anthony W Butch; Kathryn Anastos; Mardge H Cohen; Marek Nowicki; Anjali Sharma; Mary A Young; Mark J Sarnak; Chirag R Parikh Journal: J Acquir Immune Defic Syndr Date: 2012-12-15 Impact factor: 3.731
Authors: Colleen Hadigan; Elizabeth Edwards; Alice Rosenberg; Julia B Purdy; Estee Fleischman; Lilian Howard; JoAnn M Mican; Karmini Sampath; Akinbowale Oyalowo; Antoinette Johnson; Alexandra Adler; Catherine Rehm; Margo Smith; Leon Lai; Jeffrey B Kopp Journal: Am J Nephrol Date: 2013-04-20 Impact factor: 3.754